The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α

Virology

Volumn 277, Issue 2, 2000, Pages 411-419

  Barnard, P ^a   Payne, E ^a   McMillan, N A J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ONCOPROTEIN; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0034715829     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0584     Document Type: Article

References (30)

1. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line
2. Interferon response depends on viral transcription in human papillomavirus-containing lesions
3. Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum
4. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation
5. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
6. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IB-SCC) Study Group
7. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
8. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins
9. Papillomatosis and condylomata acuminata
10. Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis
11. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene
12. Regions of human papillomavirus type 16 E17 onconprotein required for immortalization of human keratinocytes
13. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons
14. Inhibition of interferon-inducible gene expression by adenoviral E1A proteins: Block in transcriptional complex formation
15. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein
16. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha
17. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
18. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
19. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
20. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway
21. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
22. Interferon treatment of human genital papillomavirus infection: Importance of viral type
23. An ELISA capture assay for the E7 transforming proteins of HPV16 and HPV18
24. Human papillomavirus and anogenital cancers
25. Papillomaviruses
26. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression
27. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
28. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma
29. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells